Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Effects of Type 1 Insulin-Like Growth Factor Receptor Silencing in a Human Adrenocortical Cell Line

Full text
Author(s):
Ribeiro, T. C. [1] ; Jorge, A. A. [1, 2] ; Montenegro, L. R. [1] ; Almeida, M. Q. [1] ; Ferraz-de-Souza, B. [3] ; Nishi, M. Y. [1] ; Mendonca, B. B. [1] ; Latronico, A. C. [1]
Total Authors: 8
Affiliation:
[1] Univ Sao Paulo, Lab Hormonios & Genet Mol, Fac Med, Unidade Endocrinol Desenvolvimento, LIM 42, Sao Paulo - Brazil
[2] Univ Sao Paulo, Lab Endocrinol Celular & Mol, Fac Med, Unidade Endocrinol Genet, LIM 25, Sao Paulo - Brazil
[3] Univ Sao Paulo, Lab Carboidratos & Radioimunoensaios LIM 18, Unidade Doencas Osteometab, Disciplina Endocrinol & Metabol, Fac Med, Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Hormone and Metabolic Research; v. 48, n. 7, p. 484-488, JUL 2016.
Web of Science Citations: 2
Abstract

Type 1 insulin-like growth factor receptor (IGF-1R) is overexpressed in a variety of human cancers, including adrenocortical tumors. The aim of the work was to investigate the effects of IGF-1R downregulation in a human adrenocortical cell line by small interfering RNA (siRNA). The human adrenocortical tumor cell line NCI H295R was transfected with 2 specific IGF1R siRNAs (\#1 and \#2) and compared with untreated cells and a negative control siRNA. IGF1R expression was determined by quantitative reverse-transcription PCR (qRTPCR) and Western blot. The effects of IGF-1R downregulation on cell proliferation and apoptosis were assessed. IGF-1R levels were significantly decreased in cells treated with IGF1R siRNA \#1 or \#2. Relative expression of IGF1R mRNA decreased approximately 50 % and Western blot analysis revealed a 30 % of reduction in IGF-1R protein. Downregulation of this gene resulted in 40 % reduction in cell growth in vitro and 45 % increase in apoptosis using siRNA \#2. These findings demonstrate that decreasing IGF1R mRNA and protein expression in NCI H295R cells can partially inhibit adrenal tumor cell growth in vitro. Targeting IGF-1R is a promising therapy for pediatric malignant adrenocortical tumor and can still be an option for adult adrenocortical cancer based on personalized genomic tumor profiling. (AU)

FAPESP's process: 10/09503-7 - Analysis of IGF1R gene silencing effects in human adrenocortical tumors lines.
Grantee:Tamaya Castro Ribeiro
Support Opportunities: Scholarships in Brazil - Doctorate